Neurodegeneration: MicroRNA

microRNAs (miRNAs) are key regulatory RNAs that control modulate gene expression in various biological processes and neurodegenerative disorders. Here are the latest discoveries pertaining to miRNAs and neurodegeneration.

August 11, 2020
Open Access

The Effect of Lithium on Inflammation-Associated Genes in Lipopolysaccharide-Activated Raw 264.7 Macrophages

International Journal of Inflammation
Raymond T MakolaThabe M Matsebatlela
September 12, 2020

The conserved microRNA miR-210 regulates lipid metabolism and photoreceptor maintenance in the Drosophila retina

Cell Death and Differentiation
Jialan LyuWanzhong Ge
September 3, 2020
Open Access

Differential Expression and miRNA-Gene Interactions in Early and Late Mild Cognitive Impairment

Biology
Leonardo Miranda BritoGilderlanio Santana de Araújo
August 9, 2020
Review
Open Access

Extracellular Vesicle Proteins and MicroRNAs as Biomarkers for Traumatic Brain Injury

Frontiers in Neurology
Vivian A GuedesJessica M Gill
August 31, 2020

Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients

Multiple Sclerosis and Related Disorders
Morteza IzadiMajid Ahmadi
August 11, 2020

Treating Alzheimer's Disease (AD) with Light and Sound

Journal of Alzheimer's Disease & Parkinsonism
Walter J Lukiw
August 14, 2020
Review
Open Access

Small RNAs, Big Diseases

International Journal of Molecular Sciences
Iwona Rzeszutek, Aditi Singh
August 21, 2020

Dimethyl Fumarate Mitigates Tauopathy in Aβ-Induced Neuroblastoma SH-SY5Y Cells

Neurochemical Research
Mithun Singh RajputRashmi Dahima
August 26, 2020

Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2016-2019)

Expert Opinion on Therapeutic Patents
Carlos Roca, Nuria E Campillo
September 17, 2020
Open Access

Dim Light at Night Induced Neurodegeneration and Ameliorative Effect of Curcumin

Cells
Dhondup NamgyalMaryam Sarwat
August 21, 2020

MicroRNA-99b-3p promotes angiotensin II-induced cardiac fibrosis in mice by targeting GSK-3β

Acta Pharmacologica Sinica
You-Hui YuJian-Tao Ye
September 10, 2020
Review
Open Access

Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease

Biomolecules
Emilia PascaleMassimiliano Caiazzo
August 26, 2020
Open Access

SARS-CoV-2 Infectivity and Neurological Targets in the Brain

Cellular and Molecular Neurobiology
Walter J LukiwJames M Hill

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/neurodegeneration-microrna/f60c606d-137a-42d7-b5fe-8ce5ed81795f